 |
 |
- Search
Search
- Page Path
-
- HOME
- Search
- Gynecologic Oncology
- Lenvatinib and pembrolizumab versus platinum doublet chemotherapy as second-line therapy for advanced or recurrent endometrial cancer
- Yutaka Yoneoka, Tsukuru Amano, Akimasa Takahashi, Hiroki Nishimura, Mari Deguchi, Hiroyuki Yamanaka, Yuji Tanaka, Shunichiro Tsuji, Takashi Murakami
- Obstet Gynecol Sci. 2024;67(6):534-540. Published online September 27, 2024
- Full text PubReader ePub PDF
- ARTICLE & TOPICS
- Editorial Office
-
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2266-7238 Fax: +82-2-3445-2440 E-mail: journal@ogscience.org
Copyright © 2024 by Korean Society of Obstetrics and Gynecology.
